Information:
Fel:
ID
45660
Beskrivning
Principal Investigator: John Thomas Poirier, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA MeSH: Lung Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001249 Genetic and epigenetic analysis of patient-derived xenograft models of acquired chemoresistance in small cell lung cancer.
Länk
Nyckelord
Versioner (1)
- 2023-03-23 2023-03-23 - Simon Heim
Rättsinnehavare
John Thomas Poirier, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Uppladdad den
23 mars 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001249 Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts
Sample ID, analyte type, body site, genotyping center, histological type, chemoresistance status, tumor status of sample, primary of metastatic tumor, primary tumor location, sequencing center, and treatment of participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
- Sample ID, analyte type, body site, genotyping center, histological type, chemoresistance status, tumor status of sample, primary of metastatic tumor, primary tumor location, sequencing center, and treatment of participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
Similar models
Sample ID, analyte type, body site, genotyping center, histological type, chemoresistance status, tumor status of sample, primary of metastatic tumor, primary tumor location, sequencing center, and treatment of participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
- Sample ID, analyte type, body site, genotyping center, histological type, chemoresistance status, tumor status of sample, primary of metastatic tumor, primary tumor location, sequencing center, and treatment of participants with small cell lung tumor and involved in the "Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived Xenografts" project.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
SAMPLE_ID
Item
De-identified sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
CL Item
Is not a tumor (N)
C0027651 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,2])
CL Item
Is tumor (Y)
C0027651 (UMLS CUI [1,1])
HISTOLOGICAL_TYPE
Item
Cell or tissue type or subtype of sample
string
C2347026 (UMLS CUI [1,1])
C0007634 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C2347026 (UMLS CUI [2,1])
C0007634 (UMLS CUI [2,2])
C0449560 (UMLS CUI [2,3])
C1292533 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C1292533 (UMLS CUI [4,1])
C0449560 (UMLS CUI [4,2])
C0007634 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C2347026 (UMLS CUI [2,1])
C0007634 (UMLS CUI [2,2])
C0449560 (UMLS CUI [2,3])
C1292533 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C1292533 (UMLS CUI [4,1])
C0449560 (UMLS CUI [4,2])
PRIMARY_METASTATIC_TUMOR
Item
Primary tumor, metastasis, or transformed cell line
string
C0677930 (UMLS CUI [1,1])
C0027627 (UMLS CUI [2,1])
C0007601 (UMLS CUI [3,1])
C0027627 (UMLS CUI [2,1])
C0007601 (UMLS CUI [3,1])
PRIMARY_TUMOR_LOCATION
Item
Primary tumor location
string
C0475447 (UMLS CUI [1,1])
GENOTYPING_CENTER
Item
Name of the center which conducted genotyping
string
C0027365 (UMLS CUI [1,1])
C5575037 (UMLS CUI [1,2])
C1285573 (UMLS CUI [1,3])
C5575037 (UMLS CUI [1,2])
C1285573 (UMLS CUI [1,3])
SEQUENCING_CENTER
Item
Name of the center which conducted sequencing
string
C0027365 (UMLS CUI [1,1])
C5575037 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
C5575037 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
Item
Chemoresistance status
text
C3665472 (UMLS CUI [1,1])
C1442099 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
C1442099 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
CL Item
Is not chemoresistant (N)
CL Item
Is chemoresistant (Y)
TREATMENT
Item
Name of treatment
string
C2826274 (UMLS CUI [1,1])
Inga kommentarer